PAIT-survey-Prevalence of albuminuria in patients with diabetes and hypertension in Turkey
PRIMARY CARE DIABETES, cilt.12, sa.6, ss.558-564, 2018 (SCI-Expanded)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 12 Sayı: 6
- Basım Tarihi: 2018
- Doi Numarası: 10.1016/j.pcd.2018.08.008
- Dergi Adı: PRIMARY CARE DIABETES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
- Sayfa Sayıları: ss.558-564
- Anahtar Kelimeler: Albuminuria, Diabetes, Hypertension, RAAS inhibitors, CHRONIC KIDNEY-DISEASE, GLOMERULAR-FILTRATION-RATE, CARDIOVASCULAR RISK-FACTORS, COLLABORATIVE METAANALYSIS, GLUCOSE CONTROL, BLOOD-PRESSURE, RENAL-DISEASE, MICROALBUMINURIA, POPULATION, OUTCOMES
- İstanbul Üniversitesi Adresli: Hayır
Özet
Background: Albuminuria is an early marker of kidney disease in patients with diabetes and/or hypertension undetected or untreated albuminuria is a leading cause of chronic kidney disease and cardiovascular events, The purpose of the present survey was to assess the prevalence of albuminuria in patients with diabetes and hypertension, treated with a combinations of renin angiotensin aldosterone system inhibitors and dihydropyridine calcium channel blockers.